Clinical Trial Update: A Pilot Trial of Oral Topotecan for the Treatment of Refractory Advanced Solid Neoplasms Expressing HIF-1a [Phase 1]

View source ↗

Summary

This Phase 1 pilot trial evaluated the safety, tolerability, and preliminary activity of oral topotecan in patients with refractory advanced solid tumors expres…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• Topotecan (topotecan)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Neoplasms | Phase 1 | Status: COMPLETED